Xia Yinchuan, Zhang Junqi, Ni Xiaoling
Department of Oncology, Bazhong Central Hospital, Bazhong, Sichuan 636000, P.R. China.
Oncol Lett. 2020 Oct;20(4):101. doi: 10.3892/ol.2020.11962. Epub 2020 Aug 7.
Although tumor thrombus (TT) infringement of the inferior vena cava (IVC) and right atrium (RA) is rarely observed in hepatocellular carcinoma (HCC), the prognosis for this condition is extremely poor, with a median survival time of several months, given that the condition is often diagnosed at an advanced tumor stage or combined with multiple systemic metastases. Furthermore, there is no established effective treatment for the condition. However, some investigators insist that active treatment, including surgery, chemotherapy (systemic or intra-arterial), radiation therapy, best supportive care or a combination of these, may help prolong overall survival time in these patients. The management of patients with advanced HCC and a TT extending into the RA and IVC is extremely difficult and risky. To this end, the present review assessed the literature on the clinical features and treatments of this condition in recent years, with the aim of providing assistance for clinical work.
尽管在肝细胞癌(HCC)中很少观察到肿瘤血栓(TT)侵犯下腔静脉(IVC)和右心房(RA),但这种情况的预后极差,中位生存时间仅为几个月,因为该疾病通常在肿瘤晚期被诊断出来或合并有多个系统转移。此外,目前尚无针对该疾病的确立有效的治疗方法。然而,一些研究人员坚持认为,积极的治疗,包括手术、化疗(全身或动脉内)、放射治疗、最佳支持治疗或这些方法的联合应用,可能有助于延长这些患者的总生存时间。晚期HCC合并TT延伸至RA和IVC的患者的管理极其困难且风险很大。为此,本综述评估了近年来关于这种情况的临床特征和治疗的文献,旨在为临床工作提供帮助。